Sarcopenia - Epidemiology Forecast To 2023 Report provides
an overview of the epidemiology trends of Sarcopenia in seven major markets
(US, France, Germany, Italy, Spain, UK and Japan). It includes historical and
forecasted epidemiological data for the prevalent cases of Sarcopenia from
2013-2023.
Sarcopenia is the progressive loss of skeletal muscle that
comes with aging. Sarcopenia is multifactorial in cause. Most people begin to
lose modest amounts of muscle mass after age 30, but the resulting loss of
strength increases exponentially with age. Of the contributory factors relating
to the development of sarcopenia inadequate protein intake, increased
splanchnic extraction of amino acids, decreased muscular response to
postprandial anabolic stimuli and vitamin D deficiency are directly related to
nutrition.
According to Publisher, the prevalent cases of Sarcopenia in
7 MM are expected to increase and reach up to 42,969,489 cases by the end of
year 2023.
The report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house Forecast
model analysis by Publisher team of industry experts.
Key Coverage and Benefits:
The report will help in developing business strategies by
understanding the trends shaping and driving the global epidemiology of
Sarcopenia.
Identifying prevalent patient populations as well as risk
factors of Sarcopenia.
Spanning over 51 pages “Sarcopenia -
Epidemiology Forecast To 2023” report covers Report Introduction,
Sarcopenia: Overview, Introduction, Sarcopenia categories and stages, Appendix.
For
more information Visit at: http://mrr.cm/USD
Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.